FGF-20, human recombinant protein
Fibroblast Growth Factor-20, FGFK
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9NP95 |
---|---|
Calculated MW | 23.2 kDa |
Gene ID | 26281 |
---|---|
Gene Symbol | FGF20 |
Other Names | Fibroblast Growth Factor-20, FGFK |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥90% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Results | <10 ng/ml |
Target/Specificity | FGF-20 |
Application Notes | Reconstitute in H₂O to a concentration of 0.1 to 1.0 mg/ml. This solution can then be diluted into other aqueous buffers |
Format | Lyophilized protein |
Storage | -20°C; Lyophilized from 20 mM Tris, pH 7.6 + 1.5 M NaCl. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Fibroblast Growth Factor-20 (FGF-20) is a secreted heparin binding growth factor belonging to the FGF family. FGF-20 signals through the FGFR 2c and 3c and is expressed during limb and brian development. Recombinant human FGF-20 is a 23.2 kDa protein containing 209 amino acid residues.
References
Kirikoshi H.,et al.Biochem. Biophys. Res. Commun. 274:337-343(2000).
Ohmachi S.,et al.Biochem. Biophys. Res. Commun. 277:355-360(2000).
Jeffers M.,et al.Cancer Res. 61:3131-3138(2001).
Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
Zhang X.,et al.J. Biol. Chem. 281:15694-15700(2006).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.